ANDREWS DEBORAH J has filed 5 insider transactions across 2 companies since July 2024.
Most recent transaction: a grant/award of 39809 shares of STAAR SURGICAL CO ($STAA) on March 13, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 13, 2026 | STAAR SURGICAL CO | $STAA | ANDREWS DEBORAH J | Interim Co-CEO and CFO | A | Restricted Stock Units | 39809 | $0.00 | 39,809.0000 | 50,549,000 | 9999.99% | 0.08% |
| Feb. 2, 2026 | STAAR SURGICAL CO | $STAA | ANDREWS DEBORAH J | Interim Co-CEO and CFO | A | Restricted Stock Units | 20787 | $0.00 | 20,787.0000 | 50,549,000 | 9999.99% | 0.04% |
| July 1, 2025 | Lineage Cell Therapeutics, Inc. | $LCTX | ANDREWS DEBORAH J | Not found | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 220,416,326 | 9999.99% | 0.03% |
| June 25, 2025 | STAAR SURGICAL CO | $STAA | ANDREWS DEBORAH J | CFO | A | Restricted Stock Units | 41867 | $0.00 | 41,867.0000 | 49,125,000 | 9999.99% | 0.09% |
| July 1, 2024 | Lineage Cell Therapeutics, Inc. | $LCTX | ANDREWS DEBORAH J | Not found | A | Stock Option (Right to Buy) | 75000 | $0.00 | 75,000.0000 | 174,987,000 | 9999.99% | 0.04% |